###begin article-title 0
###xml 8 30 8 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 8 30 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 108 113 <span type="species:ncbi:9606">Human</span>
SpeB of Streptococcus pyogenes Differentially Modulates Antibacterial and Receptor Activating Properties of Human Chemokines
###end article-title 0
###begin p 1
Conceived and designed the experiments: AE HL MC. Performed the experiments: AIO HL MY MM AK MC. Analyzed the data: AE AIO HL MM AK MC. Contributed reagents/materials/analysis tools: AE AIO MM AK MC. Wrote the paper: MC.
###end p 1
###begin p 2
Current address: Section for Cardiopulmonary Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America
###end p 2
###begin p 3
Current address: Division of Microbiology, Immunology and Glycobiology (MIG), Department of Laboratory Medicine, Lund University, Lund, Sweden
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 150 172 150 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 150 172 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
CXC chemokines are induced by inflammatory stimuli in epithelial cells and some, like MIG/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11, are antibacterial for Streptococcus pyogenes.
###end p 5
###begin title 6
Methodology/Principal Findings
###end title 6
###begin p 7
###xml 10 21 10 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 10 21 <span type="species:ncbi:1314">S. pyogenes</span>
SpeB from S. pyogenes degrades a wide range of chemokines (i.e. IP10/CXCL10, I-TAC/CXCL11, PF4/CXCL4, GROalpha/CXCL1, GRObeta/CXCL2, GROgamma/CXCL3, ENA78/CXCL5, GCP-2/CXCL6, NAP-2/CXCL7, SDF-1/CXCL12, BCA-1/CXCL13, BRAK/CXCL14, SRPSOX/CXCL16, MIP-3alpha/CCL20, Lymphotactin/XCL1, and Fractalkine/CX3CL1), has no activity on IL-8/CXCL8 and RANTES/CCL5, partly degrades SRPSOX/CXCL16 and MIP-3alpha/CCL20, and releases a 6 kDa CXCL9 fragment. CXCL10 and CXCL11 loose receptor activating and antibacterial activities, while the CXCL9 fragment does not activate the receptor CXCR3 but retains its antibacterial activity.
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
SpeB destroys most of the signaling and antibacterial properties of chemokines expressed by an inflamed epithelium. The exception is CXCL9 that preserves its antibacterial activity after hydrolysis, emphasizing its role as a major antimicrobial on inflamed epithelium.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Bisno1">[1]</xref>
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Bisno2">[2]</xref>
###xml 248 251 248 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Vinh1">[3]</xref>
###xml 288 299 288 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 0 22 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 288 299 <span type="species:ncbi:1314">S. pyogenes</span>
Streptococcus pyogenes is a strictly human pathogen that preferentially colonizes the pharynx and the skin. Bacteria disseminating from the primary site may cause life-threatening sepsis, necrotizing fasciitis, and a toxic shock syndrome [1], [2], [3]. Despite the potential virulence of S. pyogenes, many individuals are healthy carriers of the bacteria in their upper airways, demonstrating that the bacteria can colonize epithelial surfaces without eliciting an inflammatory response.
###end p 11
###begin p 12
###xml 27 49 27 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 347 350 347 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Talkington1">[4]</xref>
###xml 352 355 352 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Kuo1">[5]</xref>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Lukomski1">[6]</xref>
###xml 362 365 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Lukomski2">[7]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Lukomski3">[8]</xref>
###xml 552 555 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Ashbaugh1">[9]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Ashbaugh2">[10]</xref>
###xml 876 880 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Matsuka1">[11]</xref>
###xml 882 886 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Wolf1">[12]</xref>
###xml 888 892 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Kapur1">[13]</xref>
###xml 894 898 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Kapur2">[14]</xref>
###xml 900 904 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Herwald1">[15]</xref>
###xml 906 910 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Burns1">[16]</xref>
###xml 912 916 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Schmidtchen1">[17]</xref>
###xml 918 922 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Stockbauer1">[18]</xref>
###xml 924 928 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Collin1">[19]</xref>
###xml 930 934 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Collin2">[20]</xref>
###xml 936 940 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Tsao1">[21]</xref>
###xml 27 49 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
###xml 837 842 <span type="species:ncbi:9606">human</span>
Extracellular enzymes from Streptococcus pyogenes have been extensively studied and shown to be of importance for the pathogenesis of this human pathogen. One of the most studied enzymes is the streptococcal cysteine proteinase, SpeB. Several in vitro, in vivo, and clinical studies have suggested a role for SpeB as an important virulence factor [4], [5], [6], [7], [8]. The role for SpeB as virulence factor in mouse models is not uncontroversial and there have been reports using SpeB deletion mutants indicating that SpeB is not a virulence factor [9], [10]. SpeB has the ability to degrade the human extracellular matrix protein fibronectin and vitronectin, release inflammatory mediators such as interleukin 1beta and bradykinin from their precursors, cleave or degrade immunoglobulins and complement factors, and also bind to the human cell surface receptors integrins [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21].
###end p 12
###begin p 13
###xml 366 370 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Strieter1">[22]</xref>
###xml 372 376 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Sauty1">[23]</xref>
###xml 438 439 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 494 495 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 523 527 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Baggiolini1">[24]</xref>
###xml 608 612 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Luster1">[25]</xref>
###xml 614 618 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Liao1">[26]</xref>
###xml 620 624 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Cole1">[27]</xref>
###xml 872 876 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Loetscher1">[28]</xref>
###xml 878 882 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Xanthou1">[29]</xref>
###xml 992 1000 984 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1000 1004 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Cole2">[30]</xref>
###xml 1118 1125 1110 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004769-t001">Table 1</xref>
Dendritic cells, macrophages, and T-cells that reside in sub-epithelial tissues recognize bacterial antigens, resulting in the production of T-helper 1 polarized pro-inflammatory cytokines, including IFN-gamma and TNF-alpha. These cytokines cause an inflamed phenotype of epithelial cells, resulting in the production of host defense molecules, including chemokines [22], [23]. Chemokines are divided into four groups, XC, CC, CXC, and CX3C chemokines, depending on the presence of conserved NH2-terminal cysteine residues [24]. MIG/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11 belong to the group of CXC chemokines [25], [26], [27]. They all share the ability to signal through CXC chemokine receptor 3 (CXCR3), which is present on T cells and natural killer cells. Ligand binding to the receptor results in the activation and recruitment of these cells to sites of inflammation [28], [29]. In addition to the CXCR3 interactions, CXCL9, CXCL10, and CXCL11 also possess direct antibacterial activity in vitro[30]. Several other chemokines that are investigated in the present study also possess direct antimicrobial activity (Table 1).
###end p 13
###begin title 14
Known antimicrobial activities of the chemokines used in the present study.
###end title 14
###begin p 15
###xml 65 76 65 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 260 271 260 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 365 369 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Eliasson1">[32]</xref>
###xml 65 76 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 260 271 <span type="species:ncbi:1314">S. pyogenes</span>
In a recent study, we showed that CXCL9, CXCL10, and CXCL11 kill S. pyogenes, and that in particular CXCL9, is produced at bactericidal concentration by inflamed pharyngeal cells both in vivo and in vitro[31]. Furthermore, one of the major surface proteins of S. pyogenes, the M protein, induces increased production of MIG in IFN-gamma stimulated pharyngeal cells [32].
###end p 15
###begin p 16
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-VanDenSteen1">[33]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-VandenSteen1">[34]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-VandenSteen1">[34]</xref>
Proteolytic processing can significantly alter the signaling activity of chemokines and is most likely one of the major regulatory mechanisms for chemokines. The host proteases gelatinase B/matrix metalloproteinase-9 (MMP-9) and neutrophil collagenase/MMP-8 process several CXC chemokines including CXCL9 and CXCL10 [33], [34]. MMP-9 degrades CXCL10 and cleaves CXCL9 at three different sites in its extended carboxy-terminal region, while MMP-8 degrades CXCL9 and cleaves CXCL10 at two positions [34]. It is currently not known how proteolytic processing influences the antibacterial activity of CXCL9, CXCL10, and CXCL11.
###end p 16
###begin p 17
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Potempa1">[35]</xref>
###xml 255 277 255 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Leidal1">[36]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Schmidtchen2">[37]</xref>
###xml 451 457 451 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 468 479 468 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 568 579 568 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-HidalgoGrass1">[38]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Edwards1">[39]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-HidalgoGrass2">[40]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Zinkernagel1">[41]</xref>
###xml 975 979 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Sumby1">[42]</xref>
###xml 1119 1130 1115 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 255 277 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 468 479 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 568 579 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1119 1130 <span type="species:ncbi:1314">S. pyogenes</span>
Corruption of innate immunity by bacterial proteases is a rapidly growing field of research (for a recent comprehensive review see [35]), and processing of chemokines by bacterial proteases has recently gained substantial attention. Metalloproteases from Pseudomonas aeruginosa degrade several chemokines [36]. Furthermore, an elastase from this bacterium degrades the chemokine-like antimicrobial peptide LL-37 [37]. In the same study by Schmidtchen et al. SpeB from S. pyogenes was also shown to degrade LL-37, which is of particular interest for the present study. S. pyogenes has recently been shown to produce another interesting protease, the cell wall-anchored serine protease, SpyCEP, that degrades the CXC chemokine, IL-8/CXCL8, and thus promotes resistance against of neutrophil killing [38], [39], [40], [41]. SpyCEP was very recently also shown to degrade two additional CXC chemokines, GCP-2/CXCL6 and GROalpha/CXCL1 resulting in impaired neutrophil recruitment [42]. These findings, together with previous observations concerning direct and indirect enzymatic activities on host immune factors, highlight S. pyogenes as one of the most versatile modulators of innate and adaptive immune responses.
###end p 17
###begin title 18
Results
###end title 18
###begin title 19
###xml 30 35 <span type="species:ncbi:9606">human</span>
SpeB degrades or cleaves most human chemokines, but not CXCL8 and CCL5
###end title 19
###begin p 20
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Schmidtchen2">[37]</xref>
###xml 644 651 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig. 1A</xref>
###xml 298 303 <span type="species:ncbi:9606">human</span>
Since it has been shown that the streptococcal cysteine proteinase SpeB can cleave and inactivate the antimicrobial peptide LL-37 [37], we hypothesized that SpeB also could degrade or process chemokines that share many properties with antimicrobial peptides. We therefore incubated 2 microg of the human chemokines CXCL9, CXCL10, CXCL11, CXCL4, CXCL8, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL12, CXCL13, CXCL14, CXCL16, CCL5, CCL20, CCL28, XCL1, and CX3CL1 with a small amount of SpeB (pmol range) for 2 hours. When the samples were analyzed by SDS-PAGE, this revealed that SpeB partially or completely degrades most of these chemokines (Fig. 1A). However, CCL5 and CXCL8 were completely resistant to cleavage by SpeB, and CXCL16 and CCL20 were only partly degraded. It should be added for clarity that both intact and fragmented chemokines sometimes appear as multiple bands due to oligomerization, and that CXCL9 migrates on SDS-PAGE as an apparently larger molecule than its actual mass.
###end p 20
###begin title 21
###xml 35 40 <span type="species:ncbi:9606">human</span>
SpeB degrades or processes several human chemokines.
###end title 21
###begin p 22
###xml 663 674 663 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:9606">human</span>
###xml 663 674 <span type="species:ncbi:1314">S. pyogenes</span>
Panel A: The streptococcal cysteine proteinase was incubated with human recombinant chemokines and separated on 16.5% Tris-Tricine SDS-PAGE. Chemokines (standardized ligand and common name) are indicated above the panels and presence or absence of SpeB during incubation is indicated with minus or plus signs below the panels. Panel B: Recombinant MIG/CXCL9 was incubated with 1, 0.1, or 1 pmol of active SpeB and separated on 16.5% Tris-Tricine SDS-PAGE. CXCL9 incubated with buffer alone is shown to the left. Panel C: Two micrograms of recombinant human CXCL9 was incubated with dilutions (as indicated) of sterile filtered culture supernatants from wild type S. pyogenes AP1 and SpeB-negative isogenic derivative AL1 and separated on 16.5% Tris-Tricine SDS-PAGE. CXCL9 incubated with buffer alone is shown to the left.
###end p 22
###begin p 23
###xml 38 49 38 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 514 521 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig. 1B</xref>
###xml 605 612 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig. 1B</xref>
###xml 766 773 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig. 1B</xref>
###xml 957 964 954 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig. 1B</xref>
###xml 1381 1387 1378 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g001">Fig 1C</xref>
###xml 1482 1493 1479 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 38 49 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1482 1493 <span type="species:ncbi:1314">S. pyogenes</span>
What was most interesting in relation S. pyogenes is that there were differential SpeB activities on the closely related ELR-negative CXC-chemokines CXCL9, CXCL10, and CXCL11, where CXCL9 was processed to a smaller fragment rather than being degraded, CXCL10 was almost completely degraded, and CXCL11 was completely degraded. Furthermore, SpeB processes CXCL9 at lower concentrations and the generated fragment is resistant to further degradation even after prolonged incubation or higher concentrations of SpeB (Fig. 1B and data not shown). It should be noted that in all SDS-PAGE separations except in Fig. 1B, we utilized an SDS-PAGE loading buffer containing dithiothreitol (DTT) and iodacetamide to disrupt oligomers of chemokines. In the experiments shown in Fig. 1B we used standard SDS-PAGE loading buffer only containing beta-mercaptoethanol as a reducing agent. This allows for the visualization of oligomers, and therefore our interpretation of Fig. 1B is that SpeB either aids in the disruption of CXCL9 oligomers, or has direct proteolytic activity on both monomers and oligomers of CXCL9. Furthermore, CXCL9 was partly processed to fragments, comparable to what could be seen with purified SpeB, after incubation with sterile filtered culture supernatant from wild type AP1 bacteria, while supernatant from the isogenic SpeB negative strain did not hydrolyze CXCL9 (Fig 1C). This indicates that under these conditions there is no other secreted factor than SpeB from S. pyogenes that can degrade CXCL9.
###end p 23
###begin p 24
###xml 188 199 188 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 262 273 262 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Eliasson1">[32]</xref>
###xml 188 199 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 262 273 <span type="species:ncbi:1314">S. pyogenes</span>
The three CXC chemokines CXCL9, 10, and 11 are closely related, act through the same receptor (CXCR3), are expressed in the context of streptococcal pharyngitis, are antibacterial towards S. pyogenes[31], and are induced by the cell wall-anchored M protein from S. pyogenes[32]. We therefore decided to further elucidate the receptor activating and antimicrobial activity of CXCL9, CXCL10, and CXCL11 after SpeB hydrolysis.
###end p 24
###begin title 25
CXCL9, but not CXCL10 and CXCL11 remains antibacterial after SpeB hydrolysis
###end title 25
###begin p 26
###xml 116 127 116 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 284 295 284 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 508 519 508 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g002">Fig. 2B</xref>
###xml 1021 1028 1019 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g002">Fig. 2B</xref>
###xml 1227 1234 1225 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g002">Fig. 2A</xref>
###xml 1392 1398 1388 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g002">Fig 2B</xref>
###xml 116 127 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 284 295 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 508 519 <span type="species:ncbi:1314">S. pyogenes</span>
In particular CXCL9, and to some degree CXCL10, CXCL11, seem to be important for the antibacterial activity against S. pyogenes on inflamed respiratory tract epithelium [31]. We therefore investigated how SpeB cleavage affected the antimicrobial activity of these three chemokines on S. pyogenes strain AP1 of the important M1 serotype. A viable count assay revealed that, not surprisingly, the completely degraded CXCL11 and the nearly completely degraded CXCL10 had very low or no killing activity towards S. pyogenes AP1 bacteria, while the corresponding intact CXCL10 and CXCL11 very efficiently killed the bacteria (Fig. 2B, CXCL10 and CXCL11+/-SpeB). This was also confirmed by transmission electron microscopy (TEM) of bacteria incubated with intact and SpeB-treated CXCL10 and CXCL11, where both CXCL10 and CXCL11 caused membrane disruption and disintegration of bacterial chains while SpeB-treated CXCL1010 and CXCL11 had no visible effect on that bacteria when compared to bacteria incubated with buffer alone (Fig. 2B, Control, CXCL10 and CXCL11, Buffer / SpeB). In contrast to the findings for CXCL10 and CXCL11, there was no significant difference in killing of AP1 bacteria between SpeB-treated and intact CXCL9 (Fig. 2A, CXCL9+/-SpeB). This was also confirmed by TEM where CXCL9 irrespective of SpeB-treatment caused membrane disruption and disintegration of bacterial chains (Fig 2B, CXCL9, Buffer / SpeB).
###end p 26
###begin title 27
The effect of SpeB on the antibacterial activity of 0.5 microM CXCL9, CXCL1010, and CXCL11.
###end title 27
###begin p 28
###xml 108 119 108 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 108 119 <span type="species:ncbi:1314">S. pyogenes</span>
Panel A: CXCL9, CXCL10, and CXCL11 incubated with SpeB were compared to the intact molecules for killing of S. pyogenes strain AP1. Bars represent mean bacterial killing in percent with standard deviation determined from at least three independent experiments. Panel B: Transmission electron micrographs of AP1 bacteria incubated with intact (CXCL9-11, Buffer) or SpeB treated (CXCL9-11, SpeB) CXCL9, CXCL10, and CXCL11. Control bacteria were incubated with buffer alone. Scale bar within each picture represents 1 microm.
###end p 28
###begin p 29
###xml 253 264 253 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 253 264 <span type="species:ncbi:1314">S. pyogenes</span>
Taken together, these experiments indicate that SpeB destroys the antibacterial activity of CXCL10 and CXCL11, while SpeB-processing of CXCL9 with loss of nearly half of the molecule does not influence the potent antibacterial activity of CXCL9 against S. pyogenes.
###end p 29
###begin title 30
SpeB-cleaved CXCL9 does not signal through CXCR3
###end title 30
###begin p 31
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Barrett1">[43]</xref>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g003">Fig. 3A</xref>
###xml 810 817 810 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g003">Fig. 3A</xref>
Since the SpeB-generated CXCL9 fragment had retained antibacterial activity, we decided to examine if the receptor activating properties were affected. In order to do this, we incubated CXCL9 under reducing conditions (DTT) with or without SpeB. To minimize the proteolytic activity SpeB might have on cells, we terminated the reactions using the specific cysteine proteinase inhibitor E-64 [43]. These samples were analyzed by Tris-Tricine SDS-PAGE revealing that DTT and E-64 treated CXCL migrated as an apparently slightly smaller protein than untreated CXCL9 (Fig. 3A, lanes A and C). This could possibly be explained by some minor spontaneous hydrolysis of CXCL9. In contrast, addition of SpeB to the reaction led to a complete conversion of CXCL9 into a fragment with an apparent mass of approx. 10 kDa (Fig. 3A, lane B). Intact and SpeB-treated CXCL9 was then investigated for receptor interaction by measuring their effects on intracellular calcium levels in CXCR3-transfected pre-B cells. The results show that SpeB-processed CXCL9 had lost all the receptor-stimulating capacity of intact CXCL9.
###end p 31
###begin title 32
SpeB-hydrolyzed CXCL9 does not signal through CXCR3.
###end title 32
###begin p 33
Panel A: CXCL9 was incubated with SpeB / DTT or DTT and terminated by addition of the cysteine proteinase inhibitor E-64. Samples were separate on 16.5% SDS-PAGE and compared with intact CXCL9. Panel B: Analysis of calcium flux in Fura-2 loaded CXCR3-expressing pre-B cells upon stimulation with MIG incubated with SpeB / DTT or CXCL9 incubated with DTT alone, both terminated with E-64. Peak values of the Ex340/380 ratio fluorescence curves are presented as means and standard deviations from three independent experiments.
###end p 33
###begin title 34
Identification and purification of the SpeB-generated fragment of CXCL9
###end title 34
###begin p 35
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 631 638 631 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g004">Fig. 4A</xref>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g004">Fig. 4B</xref>
###xml 918 925 918 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g004">Fig. 4B</xref>
###xml 927 928 927 928 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</underline>
The finding that SpeB-processed CXCL9 had retained antibacterial activity but lost its receptor stimulating activity was somewhat surprising. We therefore attempted to identify the SpeB-generated fragment of CXCL9 by mass spectrometry, after several failed attempts to obtain an NH2-terminal sequence by Edman degradation. CXCL9 was digested with SpeB as described above for the receptor activating experiments and analyzed using MALDI-TOF MS and matching against theoretical fragments of the known CXCL9 holopeptide. These experiments demonstrated two major CXCL9 cleavage products of 6,290.482 and 6,306.314 Dalton respectively (Fig. 4A). The Expasy FindPept tool analysis revealed that this corresponds to a peptide from CXCL9 spanning amino acids 18 to 73 with a mass error of 0.03 Da (Fig. 4B). Furthermore, the additional peak most likely represents the mass of the same peptide but with an oxidized tryptophan (Fig. 4B, W), strengthening the identification of the peptide within CXCL9. This suggests, that the proteolytic activity of SpeB on CXCL9 occurs both in the amino-terminal and carboxy-terminal part of the molecule, generating a fragment spanning the amino acids 18 to 73 of the CXCL9 holopeptide.
###end p 35
###begin title 36
CXCL9 is trimmed amino-terminally and carboxy-terminally by SpeB.
###end title 36
###begin p 37
Panel A: SpeB-processed CXCL9 was analyzed by MALDI-TOF mass spectroscopy. Masses in Dalton are indicated above the to main intensity peaks. Panel B: The primary sequence of mature CXCL9 with the proposed SpeB-generated fragment constituting amino acids 18-73 in bold. The potentially oxidized tryptophan at position 67 is underlined.
###end p 37
###begin p 38
###xml 846 853 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004769-t002">Table 2</xref>
###xml 940 946 940 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g005">Fig. 5</xref>
###xml 1038 1049 1038 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 1181 1192 1181 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 1221 1227 1221 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g005">Fig. 5</xref>
###xml 1038 1049 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1181 1192 <span type="species:ncbi:1314">S. pyogenes</span>
In order to confirm the antibacterial activity of the SpeB generated CXCL9 fragment, a peptide spanning amino acids 18 to 73 of CXCL9 was synthesized. This peptide had no receptor stimulating activity that was expected, but somewhat surprising the antibacterial activity was also very low (data not shown). This could be interpreted as a misidentification of the fragment or that the synthetic peptide did not have its functionally correct conformation. In order to elucidate this, we purified SpeB-processed CXCL9 using anion exchange chromatography. This approach is based on the fact that minor remaining fragments, especially from the carboxy-terminal end of CXCL9 are highly positively charged and would, under the conditions used, be filtrated through the column, while the 18-73 fragment with a lower pI will interact with the matrix (See Table 2). Using this method we could purify the SpeB generated CXCL9 fragment to homogeneity (Fig. 5, inset). This purified fragment was subsequently tested for antibacterial activity against S. pyogenes using the viable count assay as described above. This revealed that SpeB-generated MIG 18-73 has an antibacterial activity against S. pyogenes comparable to intact CXCL9 (Fig. 5).
###end p 38
###begin title 39
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 26 37 <span type="species:ncbi:1314">S. pyogenes</span>
Dose dependent killing of S. pyogenes killing by CXCL9 and the SpeB generated fragment.
###end title 39
###begin p 40
###xml 97 108 97 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 97 108 <span type="species:ncbi:1314">S. pyogenes</span>
The purified 18-73 SpeB generated CXCL9 fragment was compared to the intact CXCL9 for killing of S. pyogenes strain AP1. Curves represent mean bacterial killing in percent with standard error determined from at least three independent experiments. Inset: Intact CXCL9 and ion exchange chromatography purified SpeB generated CXCL9 fragment separated on 16.5% SDS-PAGE.
###end p 40
###begin title 41
Biochemical properties of CXCL10, CXCL11 and CXCL9 (intact and SpeB cleaved).
###end title 41
###begin title 42
Homology modeling of the SpeB generated CXCL9 fragment
###end title 42
###begin p 43
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g006">Fig. 6A</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-FernandezFuentes1">[44]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Malkowski1">[45]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Booth1">[46]</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Booth2">[47]</xref>
###xml 753 760 746 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g006">Fig. 6B</xref>
###xml 982 984 975 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
It was somewhat surprising that CXCL9 was much more resistant to SpeB compared to the closely related molecules CXCL10 and CXCL11. When aligning the amino acid sequences of SpeB-processed CXCL9 with CXCL10 and CXCL11, there are no obvious explanations for this phenomenon except minor stretches of divergent sequence (Fig. 6A). Therefore, we generated a structure homology model of SpeB-processed CXCL9 using the recently developed M4T method [44] with a variant form of CXCL5 [45] as template. This model was compared to the known structures of CXCL10 and CXCL11 [46], [47]. This revealed that SpeB-processed CXCL9 is strikingly similar to mature CXCL10 and CXCL11 with three amino-terminal antiparallel beta-sheets and a carboxy-terminal alpha-helix (Fig. 6B). Some of the differences that can be noted is that CXCL11 has a somewhat less compact structure compared to both CXCL9 and CXCL10 with several internal flexible loops, and that CXCL has an additional internal predicted 310-helix between the beta-sheets and the carboxy-terminal alpha-helix.
###end p 43
###begin title 44
Sequence and structural comparison of CXCL10, CXCL11, and SpeB-processed CXCL9.
###end title 44
###begin p 45
###xml 469 471 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Panel A: ClustalW alignment of the SpeB-generated fragment of CXCL9 (18-73) with mature CXCL10 and CXCL11. Amino acid identities are shown in dark grey, similarities in light grey, and consensus sequence is shown under the alignment. Panel B, visualization of the known structures of mature CXCL10 and CXCL11, and homology model of the SpeB-generated CXCL9 fragment (18-73) using a CXCL7 -variant as the template. (R)-strands are shown in yellow, 〈-helices in purple, 310-helices in blue, and loops in turquoise.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 95 106 95 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 554 565 554 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 940 951 940 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 1134 1138 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-ClarkLewis1">[48]</xref>
###xml 1368 1379 1368 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 1379 1383 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 1821 1822 1817 1818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 95 106 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 554 565 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 940 951 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1368 1379 <span type="species:ncbi:1314">S. pyogenes</span>
For the first time we show that the cysteine proteinase SpeB from the important human pathogen S. pyogenes has differential proteolytic activity on human chemokines. Most chemokines are completely degraded, while a few are partly or completely resistant to the proteolytic activity of SpeB. The differential activity seen on the closely related ELR-negative CXC chemokines CXCL9, CXCL10, and CXCL11 was particularly interesting, since these chemokines are highly expressed by inflamed pharyngeal epithelium and have strong antibacterial activity against S. pyogenes[31]. More detailed analysis of these chemokines revealed that CXCL10 and CXCL11 were completely degraded by SpeB, resulting in loss of antibacterial activity and consequently also receptor stimulating activity. In contrast, CXCL9 has a SpeB-resistant core spanning amino acids 18-73 that has no receptor stimulating activity but with retained antibacterial activity against S. pyogenes. The finding that such a fragment of CXCL9 has no CXR3-stimulating activity is in concordance with previous findings that CXCL9 1-74 and 74-103 have low or no chemotactic activities [48], and further establishes that both the carboxy-terminal and amino-terminal parts of MIG are important for activation of the receptor. Our previous finding that the synthetic peptide CXCL9 57-83 has a strong antibacterial against S. pyogenes[31] could appear as being in conflict with our present finding that synthetic CXCL9 18-73 is not antibacterial and thereby indicate a misidentification of the SpeB generated fragment. In addition to what we consider unambiguous mass spectroscopy identification, CXCL9 57-83 is derived from the putative amphiphatic alpha-helix containing a classical sequence of antibacterial amino acids. CXCL9 18-73 on the other hand is derived from the NH2-terminal region of the holopeptide, and only contains some of the COOH-terminal antibacterial motifs. Native CXCL9 (and recombinant) is held together by two disulphide bonds corresponding to what in CXCL8 and CXCL10 have been shown to be crucial for oligomerization. The peptide CXCL9 18-73 is synthesized as a linear peptide and it is very unlikely that it can adopt a structure that allows the naturally occurring oligomerization. We hypothesize that CXCL9 18-73 fragments generated by SpeB oligomerize and thereby expose their antibacterial motifs in combination, enhancing the antibacterial activity.
###end p 47
###begin p 48
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Doran1">[49]</xref>
###xml 1310 1316 1310 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004769-g006">Fig 6B</xref>
###xml 1321 1328 1321 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004769-t002">Table 2</xref>
###xml 1477 1488 1477 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 1477 1488 <span type="species:ncbi:1314">S. pyogenes</span>
The structural differences between the homology model of CXCL9 18-73 on one hand, and CXCL10 and CXCL11 on the other hand, might partly explain the SpeB resistance of this part of CXCL9; since SpeB is known to preferentially cleave extended loops [49]. Nevertheless, most of the explanation probably lies within the part of CXCL9 that is not in the model; the amino-terminal and carboxy-terminal degraded by SpeB cannot be modeled, indicating that these parts are largely unstructured or flexible. This is also supported by the fact that there currently is no experimentally determined structure of CXCL9. These potentially unstructured or flexible parts of CXCL9 might serve as "bait" for SpeB and other proteases to divert the activity from the antibacterial core of the molecule. From an evolutionary point of view, it is interesting that CXCL9 seems to have evolved towards a robust antibacterial chemokine with relatively weak receptor interaction, while CXCL10 and CXCL11 both have more efficient interaction with the receptor but are less antibacterial and more protease sensitive than CXCL9. What is very surprising is that the highly antibacterial 18-73 fragment of CXCL9 has a predicted structure that is very similar to CXCL10 and CXCL11, but is not as highly positively charged as these molecules (Fig 6B and Table 2). This might indicate that the overall structure of an chemokine is more important for antibacterial activity than overall charge, at least against S. pyogenes and possibly other related Gram-positive bacteria.
###end p 48
###begin p 49
###xml 376 387 376 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Egesten1">[31]</xref>
###xml 1027 1031 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-HidalgoGrass1">[38]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Edwards1">[39]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-HidalgoGrass2">[40]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Zinkernagel1">[41]</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Sumby2">[50]</xref>
###xml 1154 1165 1154 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 376 387 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1154 1165 <span type="species:ncbi:1314">S. pyogenes</span>
Taken together, or results indicate that SpeB has the capacity to destroy most of the signaling properties of chemokines expressed by an inflamed epithelium by degradation of CXCL10, CXCL11, and removing the signaling activity of CXCL9 through CXCR3. CXCL9 on the other hand seems to have evolved to resist the SpeB activity and to preserve its antibacterial activity towards S. pyogenes. In the context of a bacterial infection with release of several chemokines, other antimicrobial compounds, and importantly other bacterial proteins the situation is very complex and cannot be reduced to a single interaction between a protease and a substrate. For instance, the streptococcal inhibitor of complement (Sic) can probably inhibit the antibacterial activity of the SpeB generated CXCL9 fragment since it is known to inhibit intact CXCL9-11 [31]. Furthermore, the cell wall-anchored serine proteinase SpyCEP, most likely contributes to inhibition of pro-inflammatory and antibacterial activities of chemokines during infection [38], [39], [40], [41], [50]. Nevertheless, we believe that our results deepen the understanding of innate immunity control of S. pyogenes and emphasize the role for CXCL9 as one of the major antimicrobial compounds on inflamed airway epithelium.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Chemicals, bacterial strains and proteins
###end title 51
###begin p 52
###xml 162 173 162 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 314 325 314 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Collin1">[19]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Svensson1">[51]</xref>
###xml 483 494 483 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pyogenes</italic>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 687 688 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 701 702 701 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Gerlach1">[52]</xref>
###xml 942 946 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Berge1">[53]</xref>
###xml 1056 1062 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 1113 1117 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Barrett1">[43]</xref>
###xml 1142 1146 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Nyberg1">[54]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 162 173 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 314 325 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 483 494 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 609 614 <span type="species:ncbi:4932">yeast</span>
Recombinant human chemokines were purchased from Peprotech (London, UK). All other chemicals were purchased from Sigma (St Louis, MO) if not noted otherwise. The S. pyogenes strain AP1 (40/58) of serotype M1 from the WHO Collaborating Center for Reference and Research on Streptococci, Prague, Czech Republic. The S. pyogenes strain AL1 is an isogenic derivative of strain AP1 lacking active SpeB production generated as previously described [19], [51]. For maximal SpeB production, S. pyogenes was cultured in C-medium (CM) consisting of 0.5% (w/v) Proteose Peptone No. 2 (Difco, Detroit, MI) and 1.5% (w/v) yeast extract (Oxoid, Basingstoke, England) dissolved in CM buffer (10 mM K2PO4, 0.4 mM MgSO4, and 17 mM NaCl pH 7.5) [52]. When culturing strain AL1, CM was supplemented with 150 microg / ml of kanamycin. SpeB was purified from the culture supernatant of AP1 cultured in CM using ion exchange chromatography as previously described [53]. Activity of SpeB was determined by active site titration using the specific cysteine proteinase inhibitor L-trans-epoxysuccinylleucylamido(4-guanidino)butane (E-64) [43] as previously described [54]. Throughout the paper, the amount of SpeB is described as pmol active enzyme.
###end p 52
###begin title 53
Incubation of chemokines with SpeB or culture medium
###end title 53
###begin p 54
Two microg each of recombinant chemokines CXCL9, CXCL10, ICXCL11, CXCL4, CXCL8, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL12, CXCL13, CXCL14, CXCL16, CCL5, CCL20, CCL28, XCL1, and CX3CL1 were incubated with 1 pmol SpeB in PBS supplemented with 10 mM dithiothreitol (DTT) for 2 h at 37degreesC. Two microg of recombinant CXCL9 was incubated for 2 h at 37degreesC with 5, 0.5, or 0.05 microl of 0.2 microm-filtered culture medium from AP1 or AL1 in PBS supplemented with 10 mM DTT. Samples were analyzed on 16.5% Tris-Tricine SDS-PAGE and stained with Commassie Brilliant Blue.
###end p 54
###begin title 55
Viable count assay
###end title 55
###begin p 56
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
AP1 bacteria were cultured to mid-exponential growth phase in Todd-Hewitt Broth (TH) (Becton Dickinson, Sparks, MD), washed, and diluted in 10 mM Tris-HCl (pH 7.5) with 5 mM glucose. 50 microl of bacteria (2x106 colony forming units (CFU) / mL) were incubated together with chemokines, at various concentrations or buffer alone for 2 h at 37degreesC. To quantitate bactericidal activity, serial dilutions of the incubation mixtures were plated on agar-solidified TH and the number of CFUs were determined after an overnight incubation at 37degreesC.
###end p 56
###begin title 57
CXCL9/SpeB incubation, CXCR3 transfectants, and calcium flux experiments
###end title 57
###begin p 58
###xml 345 349 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Loetscher1">[28]</xref>
###xml 616 618 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 619 620 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 678 682 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Loetscher1">[28]</xref>
###xml 684 688 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Granfeldt1">[55]</xref>
###xml 690 694 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-vonTscharner1">[56]</xref>
10 microg of CXCL9 was incubated with 5 pmol SpeB in 20 microl PBS supplemented with 10 mM DTT or in PBS/DTT alone for 2 h at 37degreesC. Reactions were terminated by addition of E-64 to a final concentration of 20 microM. Samples were analyzed on 16.5% Tris-Tricine SDS-PAGE. Stable transfectants of the pre-B cell line 300-19 expressing CXCR3 [28], were used to assay for receptor dependent responsiveness to CXCL9 and SpeB-processed CXCL9, respectively. Fura-2 loaded transfectants were stimulated using 100 nM intact CXCL9, CXCL9 incubated with SpeB / DTT / E-64 as described above, or SpeB / DTT / E-64. The [Ca2+]i -related fluorescence changes were recorded as described [28], [55], [56].
###end p 58
###begin title 59
Negative staining and transmission electron microscopy
###end title 59
###begin p 60
###xml 184 188 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Tsao1">[21]</xref>
Bacteria were incubated for 2 h at 37degreesC in incubation buffer with the chemokines placed on a carbon coated copper grid and negatively stained as described by Engel and Furthmayr [21]. The samples were washed twice with water and stained on two drops 0.75% uranyl formate. Samples were observed using a Jeol JEM 1230 transmission electron microscope operated at 60 kV accelerating voltage, and recorded with a Gatan Multiscan 791 CCD camera.
###end p 60
###begin title 61
Statistical analysis
###end title 61
###begin p 62
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical significance was determined based on the Student's t-test for paired observations.
###end p 62
###begin title 63
Determination of the CXCL9 cleavage sites by MALDI-TOF Mass Spectrometry (MS)
###end title 63
###begin p 64
The CXCL9/SpeB reactions, terminated with E-64 as described above, were desalted and concentrated using C18 Ziptips (Millipore, Bedford, MA) according to the manufacturer's instructions. Briefly, the micro-columns were washed with 0.1% TFA and eluted with 1 microl 50-90% acetonitrile in 0.1% TFA directly onto MALDI Anchorchip target plates pre-spotted with 1 microl of 1 mg/ml sinnapinic acid (SA) in 90% acetonitrile / 0.1% TFA. The MALDI target plate was loaded into a Bruker Reflex III MALDI-TOF mass spectrometer (Bruker Daltonic GmbH, Bremen, Germany). The polarity of the instrument was set for positive ions with a delayed extraction and the detector for reflector mode. The acceleration voltage was 20 kV and 50-75 shots per sample were summed in each spectrum for an improved signal-to-noise ratio. Spectra were calibrated using insulin and myoglobin standards diluted to 1-2 microM and applied as above in 1 microl of 90% acetonitrile/0.1% TFA. Evaluated machine-specific protocols and settings for the mass spectrometer were used for each of the calibrants. The EXPASY server FindPept tool () was used to search for experimentally obtained peptide masses matching with the CXCL9 sequence considering mass values as well as post-translational / experimental modifications of CXCL9. Tolerance was set to 0.5 Daltons, cysteines in reduced form and methionines as well as tryptophans as oxidized.
###end p 64
###begin title 65
Purification of the SpeB-generated CXCL9 fragment
###end title 65
###begin p 66
For ion exchange purification of the SpeB generated CXCL9 fragments 200 microg of SpeB was incubated with 40 pmol SpeB and 10 mM DTT in 400 microl of PBS. The sample was applied to a HiTrap SP HP column (GE Healthcare, Uppsala, Sweden) using an Akta Prime (GE Healthcare) liquid chromatography system. The column was washed with 5 column volumes of 50 mM HEPES (pH 7.5) and proteins were eluted using a linear gradient over 25 column volumes reaching 1 M NaCl. The fractions were analyzed on SDS-PAGE and relevant fractions were pooled and concentrated using a Centricon YM 3000 (Millipore).
###end p 66
###begin title 67
Homology modeling and structural comparisons
###end title 67
###begin p 68
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-FernandezFuentes1">[44]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Malkowski1">[45]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Booth1">[46]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Booth2">[47]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Humphrey1">[57]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004769-Stone1">[58]</xref>
A homology model of the SpeB-processed form of CXCL9 was generated using Multiple Mapping Method with Multiple Templates (M4T) () [44] using a NAP-2/CXCL7 variant (PDB 1TVX) [45] as a template. The CXCL9 model and the previously determined structures of CXCL10 (PDB 1LV9) [46] and CXCL11 (PDB 1RJT) [47] were visualized using VMD 1.8.6 () [57] and high-resolution images were generated using the Tachyon ray tracer [58].
###end p 68
###begin p 69
Pia Andersson, Ulla Johannesson, Maria Baumgarten, and Veronica Johansson are acknowledged for excellent technical assistance. We are most grateful to Dr. Bernhard Moser (The Theodor Kocher Institute, University of Bern, Switzerland) for providing CXCR3 transfectants.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Streptococcal infection of skin and soft tissue.
###end article-title 71
###begin article-title 72
Acute pharyngitis.
###end article-title 72
###begin article-title 73
Rapidly progressive soft tissue infections.
###end article-title 73
###begin article-title 74
###xml 68 90 68 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 68 90 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.
###end article-title 74
###begin article-title 75
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.
###end article-title 75
###begin article-title 76
###xml 79 101 79 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 79 101 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs.
###end article-title 76
###begin article-title 77
###xml 44 66 44 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 44 66 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.
###end article-title 77
###begin article-title 78
###xml 16 38 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.
###end article-title 78
###begin article-title 79
###xml 68 74 <span type="species:ncbi:10090">murine</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
###end article-title 79
###begin article-title 80
###xml 123 129 <span type="species:ncbi:10090">murine</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.
###end article-title 80
###begin article-title 81
###xml 27 49 27 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 27 49 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.
###end article-title 81
###begin article-title 82
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
###end article-title 82
###begin article-title 83
###xml 127 152 118 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">om Streptococcus pyogenes</italic>
###xml 130 152 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Cleavage of interleukin 1beta (IL-1beta) precursor to produce active IL-1beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.
###end article-title 83
###begin article-title 84
###xml 12 34 12 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 12 34 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.
###end article-title 84
###begin article-title 85
Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism.
###end article-title 85
###begin article-title 86
###xml 72 94 72 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 72 94 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Activation of a 66-kDa human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine proteinase.
###end article-title 86
###begin article-title 87
Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin.
###end article-title 87
###begin article-title 88
###xml 73 86 73 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 159 164 <span type="species:ncbi:9606">human</span>
A natural variant of the cysteine proteinase virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3.
###end article-title 88
###begin article-title 89
###xml 37 59 37 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 37 59 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
###end article-title 89
###begin article-title 90
###xml 30 52 30 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 30 52 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
###end article-title 90
###begin article-title 91
Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis.
###end article-title 91
###begin article-title 92
Cytokines in innate host defense in the lung.
###end article-title 92
###begin article-title 93
###xml 84 89 <span type="species:ncbi:9606">human</span>
The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.
###end article-title 93
###begin article-title 94
Chemokines in pathology and medicine.
###end article-title 94
###begin article-title 95
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
###end article-title 95
###begin article-title 96
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Mig chemokine: biochemical and functional characterization.
###end article-title 96
###begin article-title 97
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.
###end article-title 97
###begin article-title 98
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.
###end article-title 98
###begin article-title 99
Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
###end article-title 99
###begin article-title 100
Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.
###end article-title 100
###begin article-title 101
###xml 68 90 68 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 68 90 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes.
###end article-title 101
###begin article-title 102
###xml 14 36 14 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 14 36 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells.
###end article-title 102
###begin article-title 103
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
###end article-title 103
###begin article-title 104
Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase.
###end article-title 104
###begin article-title 105
Corruption of innate immunity by bacterial proteases.
###end article-title 105
###begin article-title 106
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 22 44 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78.
###end article-title 106
###begin article-title 107
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.
###end article-title 107
###begin article-title 108
Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections.
###end article-title 108
###begin article-title 109
###xml 95 117 95 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 95 117 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.
###end article-title 109
###begin article-title 110
A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues.
###end article-title 110
###begin article-title 111
###xml 41 54 41 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.
###end article-title 111
###begin article-title 112
###xml 61 74 61 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response.
###end article-title 112
###begin article-title 113
L-trans-Epoxysuccinyl-leucylamido (4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
###end article-title 113
###begin article-title 114
M4T: a comparative protein structure modeling server.
###end article-title 114
###begin article-title 115
The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
###end article-title 115
###begin article-title 116
The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.
###end article-title 116
###begin article-title 117
NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).
###end article-title 117
###begin article-title 118
###xml 44 49 <span type="species:ncbi:9606">human</span>
Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.
###end article-title 118
###begin article-title 119
Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites.
###end article-title 119
###begin article-title 120
Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response.
###end article-title 120
###begin article-title 121
###xml 87 107 <span type="species:ncbi:36470">group A streptococci</span>
Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci.
###end article-title 121
###begin article-title 122
Isolation and characterization of erythrogenic toxins V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor.
###end article-title 122
###begin article-title 123
Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins.
###end article-title 123
###begin article-title 124
###xml 50 72 46 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pyogenes</italic>
###xml 50 72 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37.
###end article-title 124
###begin article-title 125
Capacitative Ca2+ influx and activation of the neutrophil respiratory burst. Different regulation of plasma membrane- and granule-localized NADPH-oxidase.
###end article-title 125
###begin article-title 126
###xml 16 21 <span type="species:ncbi:9606">human</span>
Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration.
###end article-title 126
###begin article-title 127
VMD: Visual molecular dynamics.
###end article-title 127
###begin article-title 128
An efficient library for parallel ray tracing and animation.
###end article-title 128
###begin article-title 129
Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.
###end article-title 129
###begin article-title 130
###xml 68 73 <span type="species:ncbi:9606">human</span>
Structural correlates of antimicrobial efficacy in IL-8 and related human kinocidins.
###end article-title 130
###begin article-title 131
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human CXC-chemokine Granulocyte Chemotactic Protein 2 (GCP-2)/CXCL6 possesses membrane disrupting properties and is antibacterial.
###end article-title 131
###begin article-title 132
Constitutive expression of the antibacterial CXC chemokine GCP-2/CXCL6 by epithelial cells of the male reproductive tract.
###end article-title 132
###begin article-title 133
The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma.
###end article-title 133
###begin article-title 134
CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Swedish Research Council (projects 2005-4791 and 2007-2880), the Swedish Heart and Lung Foundation, the Foundations of Crafoord, Jeansson, Zoega, Kock, Bergh, Bergvall, Hedberg, Osterlund, Groschinsky, the Swedish Society of Medicine, the Royal Physiografic Society, and the Medical Faculty at Lund University. M.C. is the recipient of an Assistant Professorship from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 136

